Stay updated on Inhaled GB002 for PAH: Phase III Clinical Trial
Sign up to get notified when there's something new on the Inhaled GB002 for PAH: Phase III Clinical Trial page.

Latest updates to the Inhaled GB002 for PAH: Phase III Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 was added to the page history. The older funding notice and the Revision: v3.4.1 entry were removed.SummaryDifference0.6%

- Check21 days agoChange DetectedAdded Revision: v3.4.1 and a government funding notice. Removed Revision: v3.4.0.SummaryDifference0.7%

- Check28 days agoChange DetectedThe page now shows a glossary toggle, color-code explanation of changes, and revision labels updated to v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.8%

- Check42 days agoChange DetectedThe Record History for NCT03926793 now shows Revision: v3.3.4 added and Revision: v3.3.3 removed, reflecting a minor update to the revision history. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check63 days agoChange DetectedThe new screenshot adds Revision: v3.3.3 in the footer and removes HHS Vulnerability Disclosure and Revision: v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check85 days agoChange DetectedOnly a revision tag on the page changed, updating from v3.3.1 to v3.3.2; no study data or statuses were altered. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Inhaled GB002 for PAH: Phase III Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Inhaled GB002 for PAH: Phase III Clinical Trial page.